Top compounds associated with response to RP11-644F5.10


Feature Type Standardized
Nominal ANOVA
mRNA tamatinib CTRPv2 pan-cancer AAC 0.022 0.6
mRNA GSK4112 CTRPv2 pan-cancer AAC 0.022 0.6
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.02 0.6
mRNA salermide CTRPv2 pan-cancer AAC -0.027 0.6
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.019 0.6
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA staurosporine CTRPv2 pan-cancer AAC -0.043 0.6
mRNA B02 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA Erlotinib UHNBreast pan-cancer AAC -0.16 0.6
Download CSV